The latest closing stock price for Supernus Pharmaceuticals as of January 23, 2025 is 38.64.
An investor who bought $1,000 worth of Supernus Pharmaceuticals stock at the IPO in 2012 would have $6,196 today, roughly 6 times their original investment - a 16.39% compound annual growth rate over 13 years.
The all-time high Supernus Pharmaceuticals stock closing price was 59.85 on June 29, 2018.
The Supernus Pharmaceuticals 52-week high stock price is 39.37, which is 1.9% above the current share price.
The Supernus Pharmaceuticals 52-week low stock price is 25.53, which is 33.9% below the current share price.
The average Supernus Pharmaceuticals stock price for the last 52 weeks is 31.92.
An investor who bought $1,000 worth of Supernus Pharmaceuticals stock at the IPO in 2012 would have $6,196 today, roughly 6 times their original investment - a 16.39% compound annual growth rate over 13 years.
The all-time high Supernus Pharmaceuticals stock closing price was 59.85 on June 29, 2018.
The Supernus Pharmaceuticals 52-week high stock price is 39.37, which is 1.9% above the current share price.
The Supernus Pharmaceuticals 52-week low stock price is 25.53, which is 33.9% below the current share price.
The average Supernus Pharmaceuticals stock price for the last 52 weeks is 31.92.